A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors

NCT04925947 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Data collected did not support the study endpoints

Conditions

Thymic Carcinoma

Interventions

DRUG: KN046

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]